AbbVie Provides Update Regarding RINVOQ® for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S.
Bristol Myers Squibb Provides Update on CheckMate -651 Trial Evaluating Opdivo Plus Yervoy Versus EXTREME Regimen as First-Line Treatment for Squamous Cell Carcinoma of the Head and Neck
Medical Device Investing Johnson & Johnson Faces Class-Action Lawsuit Over Benzene-Tainted Neutrogena and Aveeno Sunscreen Products
Pharmaceutical Investing KEYTRUDA® Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery Showed Statistically Significant Event-Free Survival Result Versus Neoadjuvant Chemotherapy Alone in High-Risk Early-Stage TNBC
Medical Device Investing Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Johnson & Johnson Investigation
BioHarvest Sciences Inc. Demonstrates Industry Leading Sustainability Credentials With Inaugural Environmental Sustainability Report
Medical Device Investing Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California
Medical Device Investing Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene
